← Back to Search

Mobile App for Depression in Multiple Sclerosis (MS-CATCH Trial)

N/A
Recruiting
Led By Riley Bove, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-12 months, 0-6 months, 6-12 months
Awards & highlights

Summary

This trial aims to see if MS CATCH can improve the patient-doctor relationship and increase patient satisfaction.

Who is the study for?
This trial is for California residents aged 18-80 with Multiple Sclerosis, who can use a mobile app and have mild to moderate depression. They must be able to give consent and follow the study plan without being limited by cognitive or visual issues, and should not have bipolar disorder, schizophrenia, or schizoaffective disorder.
What is being tested?
The MS CATCH smartphone application is being tested to see if it improves patient care in those with Multiple Sclerosis and depression. It lets patients report mood symptoms regularly for their neurologist to monitor through their medical records.
What are the potential side effects?
Since this trial involves using a mobile application rather than medication, traditional side effects are not expected. However, participants may experience stress or discomfort from regular self-monitoring of depressive symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-12 months, 0-6 months, 6-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-12 months, 0-6 months, 6-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adoption (uptake) - Primary
Adoption (uptake) - Secondary
Comprehensive Mood Evaluation - Secondary
+4 more
Secondary study objectives
Adherence - Secondary
Engagement (Sustained use) - Exploratory
Engagement (Sustained use) - Exploratoy
+8 more
Other study objectives
Self-Efficacy - Exploratory
Trial retention - Exploratory

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2: 6 month "usual care", 6 month MS CATCH tool interventionExperimental Treatment1 Intervention
Participants in arm 2 will receive 6 months "usual care" followed by 6 months of MS CATCH tool intervention. These first 6 months will be used to assess the definition of "usual care".
Group II: Arm 1: 12 month MS CATCH tool interventionExperimental Treatment1 Intervention
Participants in arm 1 will receive 12 months of use of the MS CATCH tool. This will include in-visit interventions and monthly questionnaires.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,551 Previous Clinical Trials
15,257,786 Total Patients Enrolled
24 Trials studying Multiple Sclerosis
2,435 Patients Enrolled for Multiple Sclerosis
United States Department of DefenseFED
891 Previous Clinical Trials
332,378 Total Patients Enrolled
12 Trials studying Multiple Sclerosis
2,734 Patients Enrolled for Multiple Sclerosis
Riley Bove, MDPrincipal InvestigatorUniversity of California, San Francisco
6 Previous Clinical Trials
394 Total Patients Enrolled
6 Trials studying Multiple Sclerosis
394 Patients Enrolled for Multiple Sclerosis

Media Library

Arm 1: 12 month MS CATCH tool intervention Clinical Trial Eligibility Overview. Trial Name: NCT05865405 — N/A
Multiple Sclerosis Research Study Groups: Arm 1: 12 month MS CATCH tool intervention, Arm 2: 6 month "usual care", 6 month MS CATCH tool intervention
Multiple Sclerosis Clinical Trial 2023: Arm 1: 12 month MS CATCH tool intervention Highlights & Side Effects. Trial Name: NCT05865405 — N/A
Arm 1: 12 month MS CATCH tool intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05865405 — N/A
~33 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top